Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “control”

270 pharma patents match "control" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 270
Index total 30,257
Page 6 / 12

Quick answer

This filtered view shows 270 pharmaceutical patents matching "control" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

270 results for “control” · 30,257 patents in full index Clear search

  1. US 9233068

    Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  2. US 9216198

    Compositions and medical devices for controlled release of nitric oxide and methods of production thereof

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  3. US 9205048

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted
  4. US 9198645

    Controlled vesicle self-assembly in continuous two phase flow microfluidic channels

    The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  5. US 9114151

    Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria

    THE UNITED STATES OF AMERICA DEPT. OF VETERANS AFFAIRS · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  6. US 9115187

    Identification of antibodies specific for lyssaviruses and methods of their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  7. US 9101582

    Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  8. US 9072792

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted
  9. US 9066855

    Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted
  10. US 9066936

    Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent

    Takeda Pharmaceutical Company Limited · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted
  11. US 9046520

    Serologic correlates of protection against Bacillis anthracis infection

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  12. US 9034323

    Method for control of post-prandial glucose

    HALOZYME, INC. · Granted May 19, 2015 · Expires May 14, 2035

    granted
  13. US 9005649

    Methods for making controlled delivery devices having zero order kinetics

    The Board of Regents of the University of Texas System · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted
  14. US 9000141

    Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  15. US 8980322

    Controlled release composition

    Takeda Pharmaceutical Company Limited · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  16. US 8962588

    Micro-RNAS that control myosin expression and myofiber identity

    The Board of Regents of the University of Texas System · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  17. US 8946444

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    PTC THERAPEUTICS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted
  18. US 8936794

    Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted
  19. US 8883948

    Methods for extensive dark curing based on visible-light initiated, controlled radical polymerization

    The Regents of the University of Colorado · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  20. US 8865461

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  21. US 8852626

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  22. US 8846051

    Modulation of replicative fitness by deoptimization of synonymous codons

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  23. US 8846770

    Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  24. US 8846056

    Anti-RSV immunogens and methods of immunization

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted